Search Within

Dana Elizabeth Rathkopf

  1. "Cancer"
Formats
  1. Journal Article (4)
Groups
  1. Department of Medicine (4)
  2. Genitourinary Oncology Service (4)
  3. Solid Tumor Oncology Division (4)
  4. Biostatistics Service (2)
  5. Epidemiology and Biostatistics (2)
  6. GSK Faculty (2)

More Groups

People
  1. Howard Scher (3)
  2. Glenn Heller (2)
  3. Michael Morris (2)
  4. Steven Larson (2)
  5. Susan Slovin (2)
  6. Aseem Anand (1)

More People

Years
  1. 2024 (1)
  2. 2015 (1)
  3. 2013 (1)
  4. 2009 (1)
Publications
  1. Cancer (4)
Publishers
  1. Wiley Blackwell (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial
    Journal Article

    McKay, R. R.; Xie, W.; Yang, X.; Acosta, A.; Rathkopf, D.; Laudone, V. P.; Bubley, G. J.; Einstein, D. J.; Chang, P.; Wagner, A. A.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications
    Journal Article

    Rathkopf, D. E.; Larson, S. M.; Anand, A.; Morris, M. J.; Slovin, S. F.; Shaffer, D. R.; Heller, G.; Carver, B.; Rosen, N.; Scher, H. I.
    Cancer (2015)

    Fulltext@MSK | Save
  • Repetitively dosed docetaxel and 153samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer
    Journal Article

    Autio, K. A.; Pandit-Taskar, N.; Carrasquillo, J. A.; Stephenson, R. D.; Slovin, S. F.; Rathkopf, D. E.; Hong, C.; Heller, G.; Scher, H. I.; Larson, S. M.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago phase 2 consortium
    Journal Article

    Bradley, D.; Rathkopf, D.; Dunn, R.; Stadler, W. M.; Liu, G.; Smith, D. C.; Pili, R.; Zwiebel, J.; Scher, H.; Hussain, M.
    Cancer (2009)

    Fulltext@MSK | Save